RecruitingAdvanced Solid Tumor
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
Eligible age
18+ yrs
Accepts
All genders
Locations
13 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the safety, tolerability, and efficacy of valemetostat tosylate in combination with DXd ADC in patients with advanced solid tumors.
Sponsor: Daiichi Sankyo
Where it's recruiting
California
Irvine · Los Angeles · San Diego
Florida
Plantation · Tampa
Hawaii
Honolulu
Illinois
Chicago
Massachusetts
Boston
New York
New York · Westbury
North Carolina
Chapel Hill
Ohio
Cleveland
Oregon
Portland
Texas
Dallas · Houston
Virginia
Fairfax
Washington
Seattle
Source: ClinicalTrials.gov · NCT06244485 · last updated 2026-02-04